早期肿瘤退缩与肿瘤预后相关性的研究现状

doi:10.11904/j.issn.1002-3070.2016.01.011

Abstract

Abstract: Early tumor shrinkage(ETS)is defined as the reduction rate of tumor volume evaluated in early treatment.In recent years,mutiple studies have demonstrated that ETS predicted tumor prognosis well,it can be used as an important predictor of prognosis.Finding a predictor in the early phase of treatment can optimize treatment regimens and ameliorate the prognosis of tumor.We summarize the research progress of the relationship between ETS and prognosis.

Key words: Early tumor shrinkage, Tumor, Therapy, Prognosis

CLC Number:

R730.5

ZHAO Chunquan, XV Jianyv, XV Xiangying. The present research situation on association between tumor prognosis and early tumor shrinkage[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(1): 53-56.

References

1 Teo P,Yu P,Lee WY,et al.Significant prognosticators after primary radiotherapy in 903 nondiddeminated nasopharyngeal carcinoma evaluated by computer tomography[J].Int J Radiat Oncol Biol Phys,1996,36(2):291-304.
2 Willner J,Baier K,Pfreundner L,et al.Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma[J].Acta Oncol,1999,38(8):1025-1030.
3 Chang CC,Cheu MK,Liu MT,et al.The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors[J].Head Neck,2002,24(10):940-946.
4 Kim ST,Jang KT,Lee SJ,et al.Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer[J].BMC Cancer,2015,15:530.
5 Modest DP,Laubender RP,Stintzing S,et al.Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX:An analysis of the German AIO KRK 0104 trial[J].Acta Oncologica,2013,52(5):956-962.
6 Heinemann V,Stintzing S,Modestet DP,et al.Early tumour shrinkage(ETS)and depth of response(DpR)in the treatment of patients with metastatic colorectal cancer(mCRC)[J].Euro J of Cancer,2015,(14)51:1927-1936.
7 王孝深,胡超苏,吴永如,等.鼻咽癌常规放疗中肿瘤退缩速度对预后的影响[J].中华放射肿瘤学杂志,2005,14(1):6-9.
8 Denekamp J.Tumor regression as a guide to prognosis:a study with experimental animals[J].Br J Radiol,1977,50(592):271-279.
9 Denys D,Kumar P,Wong FS,et al.The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma[J].Am J Surg,1997,174(5):561-564.
10 Okada H,Hontsu S,Miura S,et al.Changes of tumor size and tumor contrast enhancement during radiotherapy for non-small-cell lung cancer may be suggestive of treatment response[J].J Radiat Res,2012,53(2):326-332.
11 陈波,高黎,徐国镇,等.鼻咽癌放疗中影像所示肿瘤退缩情况与远期预后的关系[J].肿瘤学杂志,2009,15(5):371-375.
12 Siker ML,Tomé WA,Mehta MP,et al.Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy:how reliable,consistent,and meaningful is the effect?[J].Int J Radiat Oncol Biol Phys,2006,66(1):135-141.
13 Ramsey CR,Langen KM,Kupelian PA,et al.A technique for adaptive image-guided helical tomotherapy for lung cancer[J].Int J Radiat Oncol Biol Phys,2006,64(4):1237-1244.
14 Bosmans G,van Baardwijk A,Dekker A,et al.Intrapatient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer:A prospective clinical study[J].Int J Radiat Oncol Biol Phys,2006,66(3):748-753.
15 Fox J,Ford E,Redmond K,et al.Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2009,74(2):341-348.
16 Suzuki C,Blomqvist L,Sundin A,et al.The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy[J].Ann Oncol,2012,23(4):948-954.
17 Giessen C,Laubender RP,Fischer von Weikersthal L,et al.Early tumor shrinkage in metastatic colorectal cancer:retrospective analysis from an irinotecan-based randomized first-line trial[J].Cancer Sci,2013,104(6):718-724.
18 Douillard JY,Siena S,Peeters M,et al.Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer[J].Eur J Cancer,2015,51(10):1231-1242.
19 Petrelli F,Pietrantonio F,Cremolini C,et al.Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer:A systematic review and pooled-analysis[J].Eur J Cancer,2015,51(7):800-807.
20 Piessevaux H,Buyse M,Schlichting M,et al.Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab [J].J Clin Oncol,2013,31(30):3764-3775.
21 Krajewski KM,Franchetti Y,Nishino M,et al.10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors:a follow-up validation study[J].Oncologist,2014,19(5):507-514.
22 Miyake H,Miyazaki A,Imai S,et al.Early tumor shrinkage under treatment with first-line tyrosine kinase inhibitors as a predictor of overall survival in patients with metastatic renal cell carcinoma:a retrospective multi-institutional study in japan[J].Target Oncol,2015,4[Epub ahead of print].
23 Kim ST,Jang KT,Lee SJ,et al.Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer[J].BMC Cancer,2015,21(15):530.
24 Birchard KR,Hoang JK,Herndon JE,et al.Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival[J].Cancer,2009,115(3):581-586.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	LI Jiaqi,LUAN Jinwei,ZHANG Yu,LI Xianglan. Analysis of clinicopathological features,recurrence and metastasis in 763 triple-negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 244-249.
[3]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[4]	LIU Yishu,QU Guofan. Progress in long-chain non-coding RNA in osteosarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 266-270.
[5]	HOU Yuxue,LI Xiaoli. The research progress of Wnt7a and malignant tumors,and its relationship [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 271-275.
[6]	ZHU Lin,ZHANG Chunxia. Research progress of the nano drug-loading systems targeting tumor stem cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 276-279.
[7]	LI Shan,ZHAO Chunbo,QIAO Wenbo. Progress in the application of intraoperative radiotherapy in pancreatic cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 280-283.
[8]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[9]	XU Hui, LI Xi, ZHOU Chunshui. Screening of lung cancer tumor-associated suppressor genes using shRNA library targeting human transcriptome [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 97-102.
[10]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[11]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[12]	LIANG Hong, LI Qi, WANG Yaoxian, JIN Hong, WANG Tong, WANG Yanan, DUAN Yani, SONG Min. Interrupted time series trial for prevention of cardiovascular toxicity induced by chemotherapy in cervical cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 134-138.
[13]	MA Zhijie, WANG Fan, ZHAO Yashuang. Analysis of life quality and influencing factors in breast cancer patients with chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 149-154.
[14]	QIN Lanqun, ZOU Zhengyun. Progress in chemotherapy for malignant melanoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 167-172.
[15]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.

The present research situation on association between tumor prognosis and early tumor shrinkage

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments